한국투자글로벌제약산업육성사모투자전문회사

한국투자글로벌제약산업육성사모투자전문회사 appears in our data through filings on 티움바이오 shares, published by DART (FSS). Over a trading history stretching from 2 April 2021 to 21 April 2025, the count stands at 7 filings.

No open-market purchase appears, only 7 sales. The amount is not disclosed for 7 filings. 2025 to date brings no purchases and 1 sale.

The latest filing, published on 28 April 2025, reports an open-market sale in 티움바이오. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from DART (FSS). Past trades are no guide to future returns.